Lack of P-selectin glycoprotein ligand-1 protects mice from thrombosis after collagen/epinephrine challenge

Thrombosis Research

Volumn 127, Issue 3, 2011, Pages 228-234

  Miszti Blasius, Kornél ^a   Debreceni, Ildikó Beke ^a   Felszeghy, Szabolcs ^a   Dezso, Balázs ^a   Kappelmayer, János ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Collagen; Fibrin; Mouse; PSGL 1; Thrombosis

Indexed keywords

ADRENALIN; COLLAGEN; FIBRIN; P SELECTIN GLYCOPROTEIN LIGAND 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FIBRIN DEPOSITION; FROZEN SECTION; GENOTYPE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE COUNT; THROMBOSIS; WESTERN BLOTTING;

ANIMALS; COLLAGEN; EPINEPHRINE; FIBRIN; GENE DELETION; LEUKOCYTE COUNT; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET AGGREGATION; PLATELET COUNT; SURVIVAL ANALYSIS; THROMBIN; THROMBOSIS;

EID: 79951956172     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.11.022     Document Type: Article

References (42)

1. Cambien B, Wagner DD. A newrole in hemostasis for the adhesion receptor P-selectin. Trends Mol Med 2004;10:179-86. (Pubitemid 38410976)
2. Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000;191:1413-22. (Pubitemid 30227127)
3. Leon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A, et al. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004;103:594-600. (Pubitemid 38140092)
4. Kappelmayer J, Nagy Jr B, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004;42:475-86. (Pubitemid 38779747)
5. Klinkhardt U, Dragutinovic I, Harder S. P-selectin (CD62p) and P-selectin glycoprotein ligand-1 (PSGL-1) polymorphisms: minor phenotypic differences in the formation of platelet-leukocyte aggregates and response to clopidogrel. Int J Clin Pharmacol Ther 2005;43:255-63. (Pubitemid 40872612)
6. McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001;86:746-56. (Pubitemid 32834182)
7. Asaduzzaman M, Rahman M, Jeppsson B, Thorlacius H. P-selectin glycoprotein-ligand- 1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis. Br J Pharmacol 2009;156:307-15.
8. da Costa Martins P, García-Vallejo JJ, van Thienen JV, Fernandez-Borja M, van Gils JM, Beckers C, et al. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol 2007;27:1023-9. (Pubitemid 46641987)
9. Dold S, Laschke MW, Zhau Y, Schilling M, Menger MD, Jeppsson B, et al. P-selectin glycoprotein ligand-1-mediated leukocyte recruitment regulates hepatocellular damage in acute obstructive cholestasis in mice. Inflamm Res 2010;59:291-8.
10. Kappelmayer J, Kiss A, Karászi E, Veszprémi A, Jakó J, Kiss C. Identification of P-selectin glycoprotein ligand-1 as a usefulmarker in acutemyeloid leukaemias. Br J Haematol 2001;115:903-9. (Pubitemid 34042907)
11. Laszik Z, Jansen PJ, Cummings RD, Tedder TF, McEver RP, Moore KL. P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood 1996;88:3010-21. (Pubitemid 26357383)
12. Sperandio M, Smith ML, Forlow SB, Olson TS, Xia L, McEver RP, et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med 2003;197:1355-63. (Pubitemid 36617782)
13. Théorêt JF, Chahrour W, Yacoub D, Merhi Y. Recombinant P-selectin glycoprotein-ligand- 1 delays thrombin-induced platelet aggregation: a new role for P-selectin in early aggregation. Br J Pharmacol 2006;148:299-305. (Pubitemid 43801177)
14. Fernandes LS, Conde ID, Wayne Smith C, Kansas GS, Snapp KR, Bennet N, et al. Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting. Thromb Res 2003;111:171-7. (Pubitemid 37532856)
15. León B, Ardavín C. Monocyte migration to inflamed skin and lymph nodes is differentially controlled by L-selectin and PSGL-1. Blood 2008;111:3126-30.
16. Patel KD, Cuvelier SL, Wiehler S. Selectins: critical mediators of leukocyte recruitment. Semin Immunol 2002;14:73-81. (Pubitemid 34879383)
17. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost 2005;3:1590-6. (Pubitemid 41716543)
18. Slotta JE, Braun OO, Menger MD, Thorlacius H. Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162. Platelets 2009;20:505-12.
19. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002;8:1175-81.
20. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-7. (Pubitemid 32917347)
21. Kaplar M, Kappelmayer J, Veszpremi A, Szabo K, Udvardy M. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets 2001;12:419-22. (Pubitemid 33097236)
22. Hechler B, Lenain N, Marchese P, Vial C, Heim V, Freund M, et al. A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 2003;198:661-7. (Pubitemid 37040400)
23. DiMinno G, Silver MJ. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J Pharmacol Exp Ther 1983;225:57-60. (Pubitemid 13137003)
24. Li TT, Larrucea S, Souza S, Leal SM, López JA, Rubin EM, et al. Genetic variation responsible for mouse strain differences in integrin alpha 2 expression is associated with altered platelet responses to collagen. Blood 2004;103:3396-402. (Pubitemid 38525670)
25. Matsukawa A, Lukacs NW, Hogaboam CM, Knibbs RN, Bullard DC, Kunkel SL, et al. Mice genetically lacking endothelial selectins are resistant to the lethality in septic peritonitis. Exp Mol Pathol 2002;72:68-76. (Pubitemid 34948284)
26. Olman MA, Mackman N, Gladson CL, Moser KM, Loskutoff DJ. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest 1995;96:1621-30.
27. Renné T, Pozgajová M, Grüner S, Schuh K, Pauer HU, Burfeind P, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005;202:271-81. (Pubitemid 41043823)
28. Smyth SS, Reis ED, Väänänen H, Zhang W, Coller BS. Variable protection of beta 3-integrin-deficient mice from thrombosis initiated by different mechanisms. Blood 2001;98:1055-62.
29. Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 1999;81:177-88. (Pubitemid 29078299)
30. Wang X. Lipopolysaccharide augments venous and arterial thrombosis in the mouse. Thromb Res 2008;123:355-60.
31. Diaz-Ricart M, Brunso L, Pino M, Navalon F, Jou JM, Heras M, et al. Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters. Thromb Res 2010;126:30-5.
32. Gogolak P, Rethi B, Szatmari I, Lanyi A, Dezso B, Nagy L, et al. Differentiation of CD1a- and CD1a+monocyte-derived dendritic cells is biased by lipid environment and PPARgamma. Blood 2007;109:643-52. (Pubitemid 46105965)
33. Baïsse B, Galisson F, Giraud S, Schapira M, Spertini O. Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function. BMC Evol Biol 2007;7:166.
34. Fischer EG, Riewald M, Huang HY, Miyagi Y, Kubota Y, Mueller BM, et al. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest 1999;104:1213-21. (Pubitemid 29536292)
35. Xia L, Sperandio M, Yago T, McDaniel JM, Cummings RD, Pearson-White S, et al. P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest 2002;109:939-50. (Pubitemid 34275115)
36. Miner JJ, Xia L, Yago T, Kappelmayer J, Liu Z, Klopocki AG, et al. Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow. Blood 2008;112:2035-45.
37. Yao L, Setiadi H, Xia L, Laszik Z, Taylor FB, McEver RP. Divergent inducible expression of P-selectin and E-selectin in mice and primates. Blood 1999;94:3820-8.
38. Zarbock A, Müller H, Kuwano Y, Ley K. PSGL-1-dependent myeloid leukocyte activation. J Leukoc Biol 2009;86:1119-24.
39. Yamada S, Mayadas TN, Yuan F, Wagner DD, Hynes RO, et al. Rolling in P-selectin-deficient mice is reduced but not eliminated in the dorsal skin. Blood 1995;86:3487-92.
40. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, et al. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg 2003;38:1075-89. (Pubitemid 37409646)
41. Momi S, Falcinelli E, Giannini S, Ruggeri L, Cecchetti L, Corazzi T, et al. Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. J Exp Med 2009;206:2365-79.
42. Nigam A, Kopecky SL. Therapeutic potential of monoclonal antibodies in myocardial reperfusion injury. Am J Cardiovasc Drugs 2002;2:367-76. (Pubitemid 36104182)